{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-011080","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2024-03-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.062652+00:00","generated_at":"2026-06-04T08:45:23.352865+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Indaptus to present Decoy10 data at AACR showing immune activation","bullets":["CSO Michael Newman to present Decoy10 poster at AACR 2024 in San Diego on April 10.","Data confirm mechanism of action: Decoy bacteria activate M1 macrophages, NK, dendritic, Th1 CD4, and CD8 T cells.","Abstract published in AACR journal Cancer Research to support the findings."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-011080","json":"https://secwatch.observer/filing/0001493152-24-011080.json","markdown":"https://secwatch.observer/filing/0001493152-24-011080.md","text":"https://secwatch.observer/filing/0001493152-24-011080.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/0001493152-24-011080-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000149315224011080/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T08:45:23.352865+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}